Q2 2025 Holdings
Filed 2025-08-12 | 20 holdings | $177.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology, Inc.(CGON) | COM | 156944100 | $57.8M | 2,221,474 | 32.5% |
| Centessa Pharmaceuticals Inc(CNTA) | SPONSORED ADS | 152309100 | $16.5M | 1,253,379 | 9.3% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $13.1M | 244,900 | 7.3% |
| Alumis Inc(ALMS) | COM | 022307102 | $12.7M | 4,247,670 | 7.2% |
| Rapt Therapeutics Inc(RAPT) | COM | 75382E208 | $12.5M | 1,562,500 | 7.0% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $8.8M | 949,260 | 5.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $7.7M | 585,000 | 4.3% |
| Hinge Health Inc(HNGE) | CL A | 433313103 | $7.0M | 135,000 | 3.9% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $6.9M | 1,731,233 | 3.9% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $6.4M | 146,332 | 3.6% |
| Verastem Inc(VSTM) | COM | 92337C203 | $5.3M | 1,276,520 | 3.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $5.0M | 160,000 | 2.8% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $4.5M | 594,025 | 2.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $4.4M | 210,000 | 2.4% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $3.2M | 2,875,357 | 1.8% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $3.0M | 144,468 | 1.7% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $1.1M | 40,000 | 0.6% |
| Spyre Therapeutics Inc(SYRE) | COM | 00773J202 | $1.0M | 70,000 | 0.6% |
| Casi Pharmaceuticals Inc(CASIF) | ORD SHS | G1933S101 | $928.8K | 787,121 | 0.5% |
| Viridian Therapeutics, Inc(VRDN) | COM | 92790C104 | $27.6K | 1,974 | 0.0% |